The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding
Open accessAbstract
Covalent modification by small ubiquitin-related modifiers (SUMO) regulates p53 transcription activity through an undefined mechanism. Using reconstituted sumoylation components, we purified SUMO-1-conjugated p53 (Su-p53) to near homogeneity. Su-p53 exists in solution as a tetramer and interacts with p300 histone acetyltransferase as efficiently as the unmodified protein. Nevertheless, it fails to activate p53-dependent chromatin transcription because of its inability to bind DNA. With sequential modification assays, we found that sumoylation of p53 at K386 blocks subsequent acetylation by p300, whereas p300-acetylated p53 remains permissive for ensuing sumoylation at K386 and alleviates sumoylation-inhibited DNA binding. While preventing the free form of p53 from accessing its cognate sites, sumoylation fails to disengage prebound p53 from DNA. The sumoylation-deficient K386R protein, when expressed in p53-null cells, exhibits higher transcription activity and binds better to the endogenous p21 gene compared with the wild-type protein. These studies unravel a molecular mechanism underlying sumoylation-regulated p53 function and further uncover a new role of acetylation in antagonizing the inhibitory effect of sumoylation on p53 binding to DNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Competition between Mdm2 and other proteins for modification of these sites may therefore contribute to p53 function [127].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
Hoege, C., Pfander, B., Moldovan, G., Pyrowolakis, G., & Jentsch, S. (2002) · Nature · doi:10.1038/nature00991 · Cited by 2,202
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,711
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,287
Matunis, M. J., Coutavas, E. E., & Blobel, G. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.6.1457 · Cited by 1,199
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,095
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006
The General Transcription Machinery and General Cofactors
Thomas, M. C., & Chiang, C. (2006) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230600648736 · Cited by 992
Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3
Saitoh, H., & Hinchey, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6252 · Cited by 897
Cited by
Sorted by citations
Sumoylation: A Regulatory Protein Modification in Health and Disease
Flotho, A., & Melchior, F. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061909-093311 · Cited by 1,124
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Borrero, L. J. H., & El‐Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 805
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
SUMO and the robustness of cancer
Seeler, J.-S., & Dejean, A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.143 · Cited by 443
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392
Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
Wu, S.-Y., Lee, A.-Y., Lai, H., Zhang, H., & Chiang, C. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.12.006 · Cited by 350
p53 Acetylation: Regulation and Consequences
Reed, S. M., & Quelle, D. E. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 344
Surf the Post-translational Modification Network of p53 Regulation
Gu, B., & Zhu, W. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4283 · Cited by 252
dbPTM in 2019: exploring disease association and cross-talk of post-translational modifications
Huang, K., Lee, T.-Y., Kao, H.-J., Ma, C.-T., Lee, C.-C., Lin, T.-H., Chang, W., & Huang, H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1074 · Cited by 220
HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
Stronach, E. A., Alfraidi, A., Rama, N., Datler, C., Studd, J. B., Agarwal, R., Guney, T. G., Gourley, C., Hennessy, B. T., Mills, G. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4111 · Cited by 176
Bettermann, K., Benesch, M., Weis, S., & Haybaeck, J. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.036 · Cited by 172
SUMO association with repressor complexes, emerging routes for transcriptional control.
García-Domínguez, M., & Reyes, J. (2009) · Biochimica et Biophysica Acta · doi:10.1016/j.bbagrm.2009.07.001 · Cited by 180
SUMO-mediated regulation of DNA damage repair and responses
Sarangi, P., & Zhao, X. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.006 · Cited by 155
Massively regulated genes: the example of TP53
Hollstein, M. C., & Hainaut, P. L. (2009) · The Journal of Pathology · doi:10.1002/path.2637 · Cited by 149
Regulation of transcription factors by sumoylation
Rosonina, E., Akhter, A., Dou, Y., Babu, J., & Theivakadadcham, V. S. S. (2017) · Transcription · doi:10.1080/21541264.2017.1311829 · Cited by 137
Gorski, P. A., Jang, S. P., Jeong, D., Lee, A., Lee, P., Oh, J. G., Chepurko, V., Yang, D. K., Kwak, T. H., Eom, S. H., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313865 · Cited by 135
A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
Kim, D., Xiao, Z., Kwon, S., Sun, X., Ryerson, D., Tkac, D., Ma, P., Wu, S., Chiang, C., Zhou, E., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489527 · Cited by 126
The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA
Rabellino, A., Carter, B., Konstantinidou, G., Wu, S.-Y., Rimessi, A., Byers, L. A., Heymach, J. V., Girard, L., Chiang, C., Teruya‐Feldstein, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3159 · Cited by 122
Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation
Treuter, E., & Venteclef, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.008 · Cited by 110
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 103
Wu, S.-Y., Nin, D. S., Lee, A.-Y., Simanski, S., Kodadek, T. J., & Chiang, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.001 · Cited by 93
Pennella, M. A., Liu, Y., Woo, J. L., Kim, C. A., & Berk, A. J. (2010) · Journal of Virology · doi:10.1128/jvi.01442-10 · Cited by 89
Santiago, A., Li, D., Zhao, L., Godsey, A. C., & Liao, D. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0771 · Cited by 83
Lysine-specific modifications of p53: a matter of life and death?
Marouco, D. M., Garabadgiu, A. V., Melino, G., & Barlev, N. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1436 · Cited by 84
Crosstalk of intracellular post-translational modifications in cancer
Wu, Z., Huang, R., & Yuan, L. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108138 · Cited by 81
Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response
Hsieh, Y.-L., Kuo, H.-Y., Chang, C., Naik, M. T., Liao, P.-H., Ho, C.-C., Huang, T.-C., Jeng, J., Hsu, P., Tsai, M., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.5 · Cited by 80
The SUMO system: a master organizer of nuclear protein assemblies
Raman, N., Nayak, A., & Muller, S. (2013) · Chromosoma · doi:10.1007/s00412-013-0429-6 · Cited by 77
Post-translational modification of pregnane x receptor
Staudinger, J. L., Xu, C., Biswas, A., & Mani, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.011 · Cited by 77
Control of SUMO and Ubiquitin by ROS: Signaling and disease implications
Stankovic‐Valentin, N., & Melchior, F. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.002 · Cited by 79
Sumoylation and Regulation of Cardiac Gene Expression
Wang, J., & Schwartz, R. J. (2010) · Circulation Research · doi:10.1161/circresaha.110.220491 · Cited by 76
Boulanger, M., Chakraborty, M., Tempé, D., Piechaczyk, M., & Bossis, G. (2021) · Molecules · doi:10.3390/molecules26040828 · Cited by 75
SUMO, a small, but powerful, regulator of double-strand break repair
Garvin, A. J., & Morris, J. R. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0281 · Cited by 73
Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes
Liu, H.-W., Zhang, J., Heine, G. F., Arora, M., Özer, H. G., Onti-Srinivasan, R., Huang, K., & Parvin, J. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks819 · Cited by 78
Regulation of the p53 pathway by ubiquitin and related proteins
Hock, A., & Vousden, K. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.011 · Cited by 70
Regulation of Epithelial–Mesenchymal Transition through SUMOylation of Transcription Factors
Bogachek, M. V., Andrade, J. P. D., & Weigel, R. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2824 · Cited by 68
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022) · Oncogene · doi:10.1038/s41388-022-02331-9 · Cited by 60
MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
Stindt, M., Carter, S. A., Vigneron, A. M., Ryan, K. M., & Vousden, K. H. (2011) · Cell Cycle · doi:10.4161/cc.10.18.17436 · Cited by 62
Kung, C.-P., Khaku, S., Jennis, M., Zhou, Y., & Murphy, M. E. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0385 · Cited by 58
PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy
Naidu, S. R., Lakhter, A. J., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.21091 · Cited by 58
Sumoylation in gene regulation, human disease, and therapeutic action
Yang, X., & Chiang, C. (2013) · F1000Prime Reports · doi:10.12703/p5-45 · Cited by 56
Deciphering the PTM codes of the tumor suppressor p53
Wen, J., & Wang, D. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab047 · Cited by 55
Kim, D.-H., Kwon, S., Byun, S., Xiao, Z., Park, S. S., Wu, S.-Y., Chiang, C., KEMPER, B. W., & Kemper, J. K. (2016) · Nature Communications · doi:10.1038/ncomms12179 · Cited by 52
Ubiquitin-like modifications in the DNA damage response
Wang, Z., Zhu, W., & Xu, X. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.07.001 · Cited by 52
Yuan, H., Zhou, J., Deng, M., Liu, X., Bras, M. L., de Thé, H., Chen, S., Chen, Z., Liu, T. X., & Zhu, J. (2009) · Cell Research · doi:10.1038/cr.2009.101 · Cited by 49
Regulation of p53 stability as a therapeutic strategy for cancer
Xu, Z., Wu, W., Yan, H., Hu, Y., He, Q., & Luo, P. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114407 · Cited by 52
PML, SUMOylation, and Senescence
Ivanschitz, L., de Thé, H., & Bras, M. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00171 · Cited by 45
Bennett, R. L., Pan, Y., Christian, J., Hui, T., & May, W. S. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18999 · Cited by 45
Oshikawa, K., Matsumoto, M., Oyamada, K., & Nakayama, K. I. (2011) · Journal of Proteome Research · doi:10.1021/pr200668y · Cited by 44
The regulation of radiosensitivity by p53 and its acetylation
Zhang, J., Shen, L., & Sun, L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.015 · Cited by 45
p53 sumoylation: Mechanistic insights from reconstitution studies
Wu, S.-Y., & Cheng, C.-M. (2009) · Epigenetics · doi:10.4161/epi.4.7.10030 · Cited by 42
Wang, W., Wu, S.-Y., Lee, A.-Y., & Chiang, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290874 · Cited by 41
In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5
Hatakeyama, D., Masuda, T., Miki, R., Ohtsuki, S., & Kuzuhara, T. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.173 · Cited by 38
Substrate and Functional Diversity of Protein Lysine Post-translational Modifications
Hao, B., Chen, K., Zhai, L., Liu, M., Liu, B., & Tan, M. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae019 · Cited by 41
Chhunchha, B., Kubo, E., Fatma, N., & Singh, D. P. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.424 · Cited by 38
Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting
Liu, H., Weng, W., Guo, R., Zhou, J., Xue, J., Zhong, S., Cheng, J., Zhu, M. X., Pan, S.-J., & Li, Y. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0569-1 · Cited by 37
Ono, W., Hayashi, Y., Yokoyama, W., Kuroda, T., Kishimoto, H., Ito, I., Kimura, K., Akaogi, K., Waku, T., & Yanagisawa, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474049 · Cited by 39
MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence
Lee, J., Won, H., Park, J., Kim, H., Choi, H., Shin, D., Kang, J., Woo, J. K., Oh, S.-H., Son, T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73743 · Cited by 36
Li, X., Lan, Y., Xu, J., Zhang, W., & Wen, Z. (2012) · Development · doi:10.1242/dev.081869 · Cited by 34
Crosstalk between SUMOylation and other post-translational modifications in breast cancer
Wei, B., Yang, F., Yu, L., & Qiu, C. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00624-3 · Cited by 36
Gong, L., Liu, F., Xiong, Z., Qi, R., Luo, Z., Gong, X., Nie, Q., Sun, Q., Liu, Y.-F., Qing, W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715237115 · Cited by 32
Illuzzi, J. L., Vickers, C. A., & Kmiec, E. B. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9516-4 · Cited by 32
Guo, B., Panagiotaki, N., Warwood, S., & Sharrocks, A. D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr267 · Cited by 29
Chhunchha, B., Kubo, E., Singh, P., & Singh, D. P. (2018) · Aging · doi:10.18632/aging.101547 · Cited by 28
Heat shock transcription factor 1 is SUMOylated in the activated trimeric state
Kmiecik, S. W., Drzewicka, K., Melchior, F., & Mayer, M. P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100324 · Cited by 28
Zhao, Q., Ma, Y., Li, Z., Zhang, K., Zheng, M., & Zhang, S. (2020) · Stem Cells International · doi:10.1155/2020/8835714 · Cited by 28
Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates
Liebl, M. C., & Hofmann, T. G. (2022) · Cancers · doi:10.3390/cancers14194549 · Cited by 27
Blakeslee, W. W., Wysoczynski, C. L., Fritz, K. S., Nyborg, J. K., Churchill, M. E. A., & McKinsey, T. A. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.005 · Cited by 26
PML Degradation: Multiple Ways to Eliminate PML
Rabellino, A., & Scaglioni, P. P. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00060 · Cited by 25
Suzuki, H., Ito, R., Ikeda, K., & Tamura, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.369629 · Cited by 24
SUMO modification regulates the transcriptional activity of MAML1
Lindberg, M. J., Popko-Ścibor, A. E., Hansson, M. L., & Wallberg, A. E. (2010) · The FASEB Journal · doi:10.1096/fj.09-149401 · Cited by 24
The SUMO‐specific protease SENP1 deSUMOylates p53 and regulates its activity
Chauhan, K. M., Chen, Y., Chen, Y., Liu, A. T., Sun, X., & Dai, M. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29838 · Cited by 23
SUMO-Modification of the La Protein Facilitates Binding to mRNA In Vitro and in Cells
Kota, V., Sommer, G., Durette, C., Thibault, P., van Niekerk, E. A., Twiss, J. L., & Heise, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156365 · Cited by 21
Functional mimicry of the acetylated C‐terminal tail of p53 by a SUMO‐1 acetylated domain, SAD
Cheema, A. K., Knights, C. D., Rao, M., Catania, J., Perez, R. E., Simons, B. L., Dakshanamurthy, S., Kolukula, V. K., Tilli, M. T., Furth, P. A., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22224 · Cited by 22
Sumoylation in Cellular Senescence and Aging
Gong, L., Sun, Q., & Li, D. (2017) · Current Molecular Medicine · doi:10.2174/1566524016666161223104915 · Cited by 19
Meng, Y., & Li, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.671392 · Cited by 20
Ahmadi, S. E., Rahimian, E., Rahimi, S., Zarandi, B., Bahraini, M., Soleymani, M., Safdari, S. M., Shabannezhad, A., Jaafari, N., & Safa, M. (2024) · Biomarker Research · doi:10.1186/s40364-024-00676-9 · Cited by 22
Functions of nuclear receptors SUMOylation
Liu, W., Min De, Z. E. N. G., & Fu, N. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.007 · Cited by 19
Arabidopsis thaliana proliferating cell nuclear antigen has several potential sumoylation sites
Strzałka, W., Labecki, P., Bartnicki, F., Aggarwal, C., Rąpała‐Kozik, M., Tani, C., Tanaka, K., & Gabryś, H. (2012) · Journal of Experimental Botany · doi:10.1093/jxb/ers002 · Cited by 18
Wu, Y., Chen, Z., Hu, Y., Zengin, G., Zhang, Q., Li, M., & Sun, W. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70120 · Cited by 17
p53 SUMOylation Mediates AOPP-Induced Endothelial Senescence and Apoptosis Evasion
Chen, Y., Liu, Z., Chen, H., Huang, X., Huang, X., Yang, L., Liang, Q. D., Wei, J., Zhang, Q., Guo, X., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.795747 · Cited by 16
Horita, H. N., Law, A., & Middleton, K. M. (2018) · Proteomes · doi:10.3390/proteomes6020024 · Cited by 17
Structural and functional analysis of SMO-1, the SUMO homolog in Caenorhabditis elegans
Surana, P., Gowda, C. M., Tripathi, V., Broday, L., & Das, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186622 · Cited by 16
Construction of a SUMOylation regulator‐based prognostic model in low‐grade glioma
Li, X., & Meng, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16553 · Cited by 15
Pasupala, N., Easwaran, S., Hannan, A., Shore, D., & Mishra, K. (2012) · Eukaryotic Cell · doi:10.1128/ec.05243-11 · Cited by 15
Sumoylation of the P Protein at K254 Plays an Important Role in Growth of Parainfluenza Virus 5
Sun, D., Xu, P., & He, B. (2011) · Journal of Virology · doi:10.1128/jvi.00389-11 · Cited by 16
Ishihara, K., Fatma, N., Bhargavan, B., Chhunchha, B., Kubo, E., Dey, S., Takamura, Y., Kumar, A., & Singh, D. P. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08686.x · Cited by 14
Azzahra, S., Hanif, N., & Hermawan, A. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.7.2341 · Cited by 15
TRIM28 regulates transcriptional activity of methyl-DNA binding protein Kaiso by SUMOylation
Lobanova, Y., Filonova, G. E., Kaplun, D., Zhigalova, N., Prokhortchouk, E., & Zhenilo, S. V. (2022) · Biochimie · doi:10.1016/j.biochi.2022.10.006 · Cited by 13
Ma, C.-H., Su, B.-Y., Maciaszek, A. D., Fan, H., Guga, P., & Jayaram, M. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008193 · Cited by 13
Dietary flavonoid fisetin binds human SUMO1 and blocks sumoylation of p53
Velazhahan, V., Glaza, P., Herrera, A. I., Prakash, O., Žółkiewski, M., Geisbrecht, B. V., & Schrick, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234468 · Cited by 12
Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review)
Wang, L., Qian, J., Yang, Y., & Gu, C. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5253 · Cited by 11
HOPS and p53: thick as thieves in life and death
Fazia, M. A. D., Castelli, M., Piobbico, D., Pieroni, S., & Servillo, G. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1838772 · Cited by 9
DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain
Wang, H., Shen, Y., Li, X., Xia, J., Sun, L. J., Xu, Y., Ma, Y., Li, D., & Xiong, Y.-C. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03260-x · Cited by 9
Protein sumoylation in normal and cancer stem cells
Zhu, Q., Liang, P., Chu, C., Zhang, A., & Zhou, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1095142 · Cited by 9
Ducker, C. E., Ratnam, M., Shaw, P. E., & Layfield, R. (2022) · Protein Expression and Purification · doi:10.1016/j.pep.2022.106216 · Cited by 7
Targeting Moonlighting Enzymes in Cancer
Lin, C., Yu, M., Wu, X., Wang, H., Wei, M., & Zhang, L. (2024) · Molecules · doi:10.3390/molecules29071573 · Cited by 8
p53-Aurora A mitotic feedback loop regulates cell cycle progression and genomic stability
Chiang, C. (2012) · Cell Cycle · doi:10.4161/cc.22113 · Cited by 6
The Four Homeostasis Knights: In Balance upon Post-Translational Modifications
Pieroni, S., Castelli, M., Piobbico, D., Ferracchiato, S., Scopetti, D., Di-Iacovo, N., Fazia, M. A. D., & Servillo, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214480 · Cited by 6
In Silico Identification of SOX1 Post-Translational Modifications Highlights a Shared Protein Motif
Ahmad, A., Strohbuecker, S., Scotti, C., Tufarelli, C., & Sottile, V. (2020) · Cells · doi:10.3390/cells9112471 · Cited by 5
The role of SUMOylation in epithelial-mesenchymal transition
Li, S., Yu, X.-M., Liang, L., & Zheng, Y. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02568-3 · Cited by 4
Metadata
- Authors
- Wu, S., & Chiang, C.
- Affiliations
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Chiang, Cheng‐Ming
- Venue
- The EMBO Journal
- Published
- 2009-04-02
- Volume
- 28
- Issue
- 9
- Pages
- 1246-1259
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC2683057
- OpenAlex
- W2073590048
- Cited by
- 125
- References
- 68
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 5 · 2023: 1 · 2022: 8 · 2021: 12 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 12 · 2012: 12
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA103867, R01CA103867, R01CA124760, CA124760)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- p53, SUMOylation, acetylation, SUMO1, P300, histone acetyltransferase, p53 DNA binding, chromatin transcription, post-translational modification, p21 gene, p53 tetramer, transcriptional activation
- MeSH terms
- p300-CBP-Associated Factor, Acetylation, Chromatin, Chromatography, Gel, DNA, Humans, Protein Binding, Transcription, Genetic, Tumor Suppressor Protein p53, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Small Ubiquitin-Related Modifier Proteins, Cell Line, Tumor, Chromatin Immunoprecipitation, p300-CBP Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review